199 related articles for article (PubMed ID: 30586157)
1. Classification of factors involved in nonreportable results of noninvasive prenatal testing (NIPT) and prediction of success rate of second NIPT.
Suzumori N; Sekizawa A; Takeda E; Samura O; Sasaki A; Akaishi R; Wada S; Hamanoue H; Hirahara F; Kuriki H; Sawai H; Nakamura H; Yamada T; Miura K; Masuzaki H; Yamashita T; Kamei Y; Namba A; Murotsuki J; Tanemoto T; Fukushima A; Haino K; Tairaku S; Matsubara K; Maeda K; Kaji T; Ogawa M; Osada H; Nishizawa H; Okamoto Y; Kanagawa T; Kakigano A; Endo M; Kitagawa M; Ogawa M; Izumi S; Katagiri Y; Takeshita N; Kasai Y; Naruse K; Neki R; Masuyama H; Hyodo M; Kawano Y; Ohba T; Ichizuka K; Nagamatsu T; Watanabe A; Nishikawa N; Hamajima N; Shirato N; Yotsumoto J; Nishiyama M; Koide K; Hirose T; Sago H
Prenat Diagn; 2019 Jan; 39(2):100-106. PubMed ID: 30586157
[TBL] [Abstract][Full Text] [Related]
2. Nonreportable rates and cell-free DNA profiles in noninvasive prenatal testing among women with heparin treatment.
Nakamura N; Sasaki A; Mikami M; Nishiyama M; Akaishi R; Wada S; Ozawa N; Sago H
Prenat Diagn; 2020 Jun; 40(7):838-845. PubMed ID: 32274797
[TBL] [Abstract][Full Text] [Related]
3. [Analysis to the failure rate and causes of noninvasive prenatal testing based on high-throughput sequencing].
Wang W; Duan H; Ding W; Zhang Y; Zhu R; Li J
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Dec; 38(12):1171-1175. PubMed ID: 34839500
[TBL] [Abstract][Full Text] [Related]
4. Incidental Detection of Maternal Neoplasia in Noninvasive Prenatal Testing.
Dharajiya NG; Grosu DS; Farkas DH; McCullough RM; Almasri E; Sun Y; Kim SK; Jensen TJ; Saldivar JS; Topol EJ; van den Boom D; Ehrich M
Clin Chem; 2018 Feb; 64(2):329-335. PubMed ID: 28982650
[TBL] [Abstract][Full Text] [Related]
5. DNA sequencing versus standard prenatal aneuploidy screening.
Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
[TBL] [Abstract][Full Text] [Related]
6. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.
Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX
DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029
[TBL] [Abstract][Full Text] [Related]
7. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA
Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661
[TBL] [Abstract][Full Text] [Related]
8. Reliable noninvasive prenatal testing by massively parallel sequencing of circulating cell-free DNA from maternal plasma processed up to 24h after venipuncture.
Buysse K; Beulen L; Gomes I; Gilissen C; Keesmaat C; Janssen IM; Derks-Willemen JJ; de Ligt J; Feenstra I; Bekker MN; van Vugt JM; Geurts van Kessel A; Vissers LE; Faas BH
Clin Biochem; 2013 Dec; 46(18):1783-6. PubMed ID: 23933476
[TBL] [Abstract][Full Text] [Related]
9. [Non invasive prenatal test (NIPT) in maternal blood by parallel massive sequencing. Initial experience in Mexican women and literature review].
Hernández-Gómez M; Ramirez-Arroyo E; Meléndez-Hernández R; Garduño-Zaraza LM; Mayén-Molina DG
Ginecol Obstet Mex; 2015 May; 83(5):277-88. PubMed ID: 26233973
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146,958 pregnancies.
Zhang H; Gao Y; Jiang F; Fu M; Yuan Y; Guo Y; Zhu Z; Lin M; Liu Q; Tian Z; Zhang H; Chen F; Lau TK; Zhao L; Yi X; Yin Y; Wang W
Ultrasound Obstet Gynecol; 2015 May; 45(5):530-8. PubMed ID: 25598039
[TBL] [Abstract][Full Text] [Related]
11. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
[TBL] [Abstract][Full Text] [Related]
12. Validation of a method for noninvasive prenatal testing for fetal aneuploidies risk and considerations for its introduction in the Public Health System.
Gerundino F; Giachini C; Contini E; Benelli M; Marseglia G; Giuliani C; Marin F; Nannetti G; Lisi E; Sbernini F; Periti E; Cordisco A; Colosi E; D'ambrosio V; Mazzi M; Rossi M; Staderini L; Minuti B; Pelo E; Cicatiello R; Maruotti GM; Sglavo G; Conti A; Frusconi S; Pescucci C; Torricelli F
J Matern Fetal Neonatal Med; 2017 Mar; 30(6):710-716. PubMed ID: 27226231
[TBL] [Abstract][Full Text] [Related]
13. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result.
Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH
Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020
[TBL] [Abstract][Full Text] [Related]
14. Retrospective details of false-positive and false-negative results in non-invasive prenatal testing for fetal trisomies 21, 18 and 13.
Suzumori N; Sekizawa A; Takeda E; Samura O; Sasaki A; Akaishi R; Wada S; Hamanoue H; Hirahara F; Sawai H; Nakamura H; Yamada T; Miura K; Masuzaki H; Nakayama S; Kamei Y; Namba A; Murotsuki J; Yamaguchi M; Tairaku S; Maeda K; Kaji T; Okamoto Y; Endo M; Ogawa M; Kasai Y; Ichizuka K; Yamada N; Ida A; Miharu N; Kawaguchi S; Hasuo Y; Okazaki T; Ichikawa M; Izumi S; Kuno N; Yotsumoto J; Nishiyama M; Shirato N; Hirose T; Sago H
Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():75-81. PubMed ID: 33171421
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive prenatal testing for fetal chromosomal abnormalities by low-coverage whole-genome sequencing of maternal plasma DNA: review of 1982 consecutive cases in a single center.
Lau TK; Cheung SW; Lo PS; Pursley AN; Chan MK; Jiang F; Zhang H; Wang W; Jong LF; Yuen OK; Chan HY; Chan WS; Choy KW
Ultrasound Obstet Gynecol; 2014 Mar; 43(3):254-64. PubMed ID: 24339153
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive prenatal screening for fetal common sex chromosome aneuploidies from maternal blood.
Zhang B; Lu BY; Yu B; Zheng FX; Zhou Q; Chen YP; Zhang XQ
J Int Med Res; 2017 Apr; 45(2):621-630. PubMed ID: 28357876
[TBL] [Abstract][Full Text] [Related]
17. Feasibility of noninvasive prenatal testing for common fetal aneuploidies in an early gestational window.
Shi X; Zhang Z; Cram DS; Liu C
Clin Chim Acta; 2015 Jan; 439():24-8. PubMed ID: 25286007
[TBL] [Abstract][Full Text] [Related]
18. The importance of determining the limit of detection of non-invasive prenatal testing methods.
Fiorentino F; Bono S; Pizzuti F; Mariano M; Polverari A; Duca S; Sessa M; Baldi M; Diano L; Spinella F
Prenat Diagn; 2016 Apr; 36(4):304-11. PubMed ID: 26815144
[TBL] [Abstract][Full Text] [Related]
19. Prenatal screening for fetal aneuploidies with cell-free DNA in the general pregnancy population: a cost-effectiveness analysis.
Fairbrother G; Burigo J; Sharon T; Song K
J Matern Fetal Neonatal Med; 2016; 29(7):1160-4. PubMed ID: 26000626
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
McLennan A; Palma-Dias R; da Silva Costa F; Meagher S; Nisbet DL; Scott F
Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):22-8. PubMed ID: 26817523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
